A comparative analysis of biosimilar vs originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma%3B a propensity‐score weighted multicenter approach

A comparative analysis of biosimilar vs originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma; a propensity-score weighted multicenter approach / Lanza, F; Saraceni, F; Pezzi, A; Martino, M; Bosi, A; Cascavilla, N; Musto, P; Zuffa, E; Tani, M; Cellini, C; Laszlo, D; Bonifazi, F. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - STAMPA. - (2017), pp. 300-312. [10.1002/ajh.24817]

A comparative analysis of biosimilar vs originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma; a propensity-score weighted multicenter approach

BOSI, ALBERTO;
2017

Abstract

A comparative analysis of biosimilar vs originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma%3B a propensity‐score weighted multicenter approach
2017
300
312
Lanza, F; Saraceni, F; Pezzi, A; Martino, M; Bosi, A; Cascavilla, N; Musto, P; Zuffa, E; Tani, M; Cellini, C; Laszlo, D; Bonifazi, F
1a - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1087961
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact